Skip to main content

Table 1 Baseline characteristics of COVID-19 patients

From: Analysis of viral load in different specimen types and serum antibody levels of COVID-19 patients

Patient

Sexa

Age (years)

Time between symptom onset and sampling (days)

Severity

Underlying diseases

White-cell count (× 1000/μl)

Lymphocyte count (× 1000/μl)

Platelet count (× 1000/μl)

CRP (mg/l)

IL-6 (pg/ml)

PT (s)

APTT (s)

TT (s)

FIB (g/L)

D-dimer (μg/ml)

Urea nitrogen (mmol/l)

Serum creatinine (μmol/l)

GG01

F

42

53

Moderate

Yes

7

2.08

289

2.78

1.5

11.7

31.8

14.2

3.18

0.18

3.45

48.9

GG02

F

94

55

Moderate

No

3.3

1.08

354

2.66

91.11

11.4

28.6

17.7

2.17

4.17

5.96

43.6

GG03

M

36

7

Moderate

Yes

8.5

2.15

225

7.37

2.5

12

32.7

12.9

4.79

0.59

3.85

75.1

GG04

F

52

57

Moderate

Yes

9.5

1.32

253

18.22

GG05

F

73

56

Moderate

No

4.8

1.35

211

1.68

1.5

11.7

37.7

15.1

3.55

1.05

5.5

58.3

GG06

F

55

32

Moderate

No

4.9

1.69

175

0.21

10.5

32.3

17.2

2.6

0.23

5.59

85.3

GG07

F

65

34

Moderate

No

GG08

F

85

44

Moderate

Yes

4.1

1.13

200

1

1.5

11.7

35.9

17

2.31

0.58

3.57

57.1

GG09

M

57

16

Moderate

No

5.1

3.05

213

0.26

1.5

11.3

31.3

13.8

2.58

0.17

5.27

58.1

GG10

M

36

50

Moderate

No

5.7

1.42

239

2.84

12

32.7

14.6

3.1

0.27

3.44

53.5

GG11

F

37

48

Moderate

No

GG12

M

71

30

Severe

Yes

5.2

0.93

72

1.51

29.51

3.75

82.9

GG13

M

50

40

Moderate

No

7.7

1.95

277

0.65

4.19

77.5

GG14

M

76

46

Moderate

Yes

42.82

GG15

F

30

55

Moderate

No

3.2

0.97

140

0.57

GG16

F

43

20

Moderate

No

8.1

1.87

186

0.72

1.5

10.2

26.3

15.3

3.1

0.25

3.88

62

GG17

F

41

47

Moderate

No

5

3.21

284

1.75

8.7

28.8

14.7

3.14

0.22

4.64

58.9

GG18

M

70

36

Moderate

Yes

GG19

F

51

38

Moderate

No

5

1.77

281

0.5

1.5

GG20

F

80

42

Moderate

No

5.1

0.87

181

8.37

2.79

4.23

63.4

GG21

F

69

58

Moderate

No

5.9

1.52

141

3.67

11.6

34.8

15

2.27

0.66

5.63

60.6

GG22

F

62

39

Moderate

Yes

4.9

0.9

167

0.04

5.47

56.2

GG23

F

37

69

Moderate

No

4.7

1.69

231

0.08

1.5

11.7

29.9

14.5

2.86

0.17

3.73

50.2

GG24

F

59

52

Moderate

No

GG25

F

87

26

Severe

Yes

9.8

1.37

125

0.41

14

10.8

26.8

20.6

1.84

1.62

6.44

49.5

GG26

F

52

30

Moderate

No

3.4

1.47

343

0.08

1.5

11.9

30.4

16.8

2.38

0.16

4.49

63.3

GG27

M

55

46

Moderate

No

4.6

1.46

346

2.05

1.5

12.6

30.9

15.1

3.1

0.83

3.64

68.3

GG28

F

65

41

Moderate

No

4.1

1.36

193

1.72

7.12

53.7

GG29

F

56

57

Moderate

No

GG30

M

74

58

Moderate

Yes

6.6

1.64

322

1.03

1.5

11.5

33.3

14.5

3.14

0.15

4.11

69.2

GG31

F

86

60

Critical

Yes

11.3

1.27

180

4.9

2.06

11.7

29.6

14.3

2.93

1.6

6.18

65.2

GG32

F

46

67

Moderate

No

3.4

1.19

189

1.05

1.5

11.3

33.6

15.2

2.6

0.24

4.63

51.8

GG33

M

67

26

Critical

No

18.1

2.1

23

9.23

1554.8

18

39.5

24.9

5.64

17.67

13.17

59.5

GG34

F

80

50

Moderate

Yes

3.8

1.18

192

6.03

16.3

11.7

32.5

16.5

2.96

5.73

4.04

54.9

GG35

F

60

53

Moderate

Yes

4.2

0.9

161

0.9

1.5

11.6

25.5

16.3

2.15

0.42

5.21

50.5

GG36

F

53

42

Moderate

No

6.1

1.56

226

1.06

1.5

10.5

31.2

13.4

3.03

0.18

4.26

51.9

GG37

F

77

34

Moderate

No

6.1

1.07

25

0.78

 < 1.5

11.2

27.9

15.5

2.9

0.61

3.9

50.5

  1. aF = female, M = male